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Introduction
============

Tonometry is one of the few clinical tools available for the monitoring of tissue oxygenation \[[@B1]\]. Decreases in gastrointestinal intramucosal pH (pH~i~) have usually been considered as indicators of dysoxia \[[@B2],[@B3],[@B4],[@B5]\]; that is, as heralds of insufficient O~2~ to meet tissue demands. Recently, the intramucosal--arterial P[CO]{.smallcaps}~2~ gradient (ΔP[CO]{.smallcaps}~2~) has been claimed to be a better marker of gastrointestinal mucosal state of oxygenation \[[@B6]\]. P[CO]{.smallcaps}~2~ can increase in intestinal lumen by two mechanisms \[[@B7]\]. One is by bicarbonate buffering of protons from the breakdown of high-energy phosphates and metabolic acids generated anaerobically, such as lactate, in which case increased P[CO]{.smallcaps}~2~ would represent tissue dysoxia. Alternatively, in an aerobic state, it might be the result of hypoperfusion and decreased washout. In this latter case, oxygen metabolism could be preserved if the flow were adequate.

Grum *et al.* \[[@B2]\] found that pH~i~ and intestinal oxygen uptake (V[O]{.smallcaps}~2~) were correlated in ischemia, in hypoxemia, and in a combination of both. However, in hypoxemic experiments, neither V[O]{.smallcaps}~2~ nor pH~i~ fell. Hence, the value of tonometry in hypoxemia remains uncertain. If a rise in ΔP[CO]{.smallcaps}~2~ reflected only a decrease in blood flow, this gradient might not be altered in hypoxemia, in which cardiac output (CO) is usually maintained and even increased. Our hypothesis was that ΔP[CO]{.smallcaps}~2~ would not be modified in hypoxic hypoxia (HH) with preserved blood flow.

Methods
=======

Surgical preparation
--------------------

This study was approved by the local Animal Care Committee. Care of studied animals was in accordance with National Institutes of Health guidelines. Seventeen adult sheep (26.0 ± 9.1 kg \[mean ± SD\]) were anesthetized with 30 mg/kg sodium pentobarbital, tracheostomized and then ventilated (Harvard Pump Ventilator; Harvard Apparatus, South Natick, Massachusetts, USA) with a tidal volume of 15 ml/kg, a respiratory rate of 12 per minute, and a positive end-expiratory pressure of 5 cm H~2~O throughout the experiment. The starting fraction of inspired oxygen (F~i~[O]{.smallcaps}~2~) was 0.21. Additional pentobarbital was administered if necessary. Neuromuscular blockade was provided with a single dose of pancuronium (0.06 mg/kg). Catheters were placed into the femoral artery and vein and into the pulmonary artery (flow-directed thermod-ilution fiberoptic pulmonary artery catheter; Abbott Critical Care Systems, Mountain View, California, USA).

After performing a midline laparotomy, we performed splenectomy and a gastrostomy with drainage of gastric contents. We placed an electromagnetic blood flow transducer around the superior mesenteric artery. A catheter was advanced into the superior mesenteric vein, and a tonometer was inserted into the ileum.

Measurements and derived calculations
-------------------------------------

CO was measured in triplicate by the thermodilution technique, with 5 ml of iced saline (HP OmniCare Model 24 A 10; Hewlett Packard, Andover, Massachusetts, USA), and was referred to body weight. Superior mesenteric artery blood flow (intestinal blood flow) was measured by the electromagnetic method (Spectramed Blood Flowmeter model SP 2202 B; Spectramed Inc., Oxnard, California, USA) and indexed to intestinal weight.

Arterial mixed venous and mesenteric venous P[O]{.smallcaps}~2~, P[CO]{.smallcaps}~2~, and pH, and haemoglobin concentrations and saturations were measured with a blood gas analyzer and a co-oximeter, respectively (ABL 30 and OSM 3; Radiometer, Copenhagen, Denmark). Systemic and intestinal oxygen transport and uptake (D[O]{.smallcaps}~2~, V[O]{.smallcaps}~2~, intestinal D[O]{.smallcaps}~2~, and intestinal V[O]{.smallcaps}~2~ respectively) were calculated with standard formulae.

Intramucosal P[CO]{.smallcaps}~2~ was measured by saline tonometry (TRIP Sigmoid Catheter; Tonometrics, Inc., Worcester, Massachu-setts, USA) \[[@B8]\]. After an equilibration period of 30 minutes, 1.0 ml was discarded. P[CO]{.smallcaps}~2~ was measured in the remnant (ABL 30; Radiometer). pH~i~ and ΔP[CO]{.smallcaps}~2~ were calculated with a correction factor for the equilibration time. Kolkman *et al.* \[[@B9]\] showed that the variability of intramucosal P[CO]{.smallcaps}~2~ measurements is independent of dwell time. Assessments at short dwell times should therefore be reliable.

We calculated venoarterial and intramucosal--arterial CO~2~ content differences to evaluate the changes in the CO~2~ dissociation curve \[[@B10]\]. To compute intramucosal CO~2~ content, intramucosal P[CO]{.smallcaps}~2~, pH, and mesenteric venous oxygen saturation were considered as representative of mucosal blood.

Experimental procedure
----------------------

After a stabilization period of at least 30 minutes, we performed basal measurements (0 minutes). Sheep were then assigned to ischemic hypoxia (IH \[*n* = 6\]), HH (*n* = 6), or sham (*n* = 5) groups. In the IH group, bleeding was performed in three steps of 10 ml/kg at intervals of 30 minutes. In the HH group, 2 ml/kg 0.1 M hydrochloric acid was instilled into the trachea, and F~i~[O]{.smallcaps}~2~ was raised to 0.50. Saline solution was infused to keep intestinal blood flow constant. Measurements were repeated at 30, 60, and 90 minutes. Body temperature was maintained stable with a heating lamp.

Finally, animals were killed with supplemental pentobarbital and a KCl bolus. Indian ink was infused through the superior mesenteric artery, and dyed intestinal segments were dissected and weighed.

Statistical analysis
--------------------

Data are expressed as means ± SD except where noted otherwise. Analysis within groups was performed with a repeated-measures analysis of variance (ANOVA) and a paired *t*-test with Bonferroni correction. One-way ANOVA and unpaired *t*-test with Bonferroni correction were used for one-time comparisons. In both cases, *t*-tests were used when ANOVA results were significant; *P* \< 0.05 was considered significant.

Results
=======

Hemoglobin concentration, and arterial, mixed venous, and mesenteric venous blood gases and oxygen saturations in basal conditions, and during IH and HH and in the sham group are shown in Table [1](#T1){ref-type="table"}.

###### 

Hemoglobin concentration and arterial, mixed venous, and mesenteric venous blood gases and oxygen saturations in basal conditions and during ischemic hypoxia (HI) and hypoxic hypoxia (HH), and in the sham group

  Parameter                                       Group   Basal         30 minutes          60 minutes          90 minutes
  ----------------------------------------------- ------- ------------- ------------------- ------------------- -------------------
  Hemoglobin (g%)                                 IH      9.1 ± 0.6     8.6 ± 0.6           7.9 ± 1.1^\*^       7.4 ± 1.3^\*^
                                                  HH      10.2 ± 1.2    10.7 ± 1.0‡‡        11.2 ± 1.1‡‡        11.4 ± 1.2^\*^‡‡
                                                  SHAM    10.7 ± 1.6    11.0 ± 1.4‡‡        11.4 ± 1.3‡‡        11.2 ± 1.1‡‡
  Arterial pH                                     IH      7.36 ± 0.10   7.35 ± 0.07         7.31 ± 0.10         7.25 ± 0.11^\*^
                                                  HH      7.41 ± 0.07   7.26 ± 0.10^\*\*^   7.21 ± 0.12^\*\*^   7.15 ± 0.13^\*\*^
                                                  SHAM    7.37 ± 0.09   7.39 ± 0.10         7.38 ± 0.10         7.36 ± 0.13
  Arterial P[CO]{.smallcaps}~2~ (mmHg)            IH      33 ± 3        31 ± 4              28 ± 3^\*\*^†       24 ± 4^\*\*^††
                                                  HH      29 ± 3        40 ± 8^\*^          45 ± 11^\*^         49 ± 13^\*\*^
                                                  SHAM    30 ± 4        28 ± 3†             28 ± 3†             28 ± 6†
  Arterial P[O]{.smallcaps}~2~ (mmHg)             IH      79 ± 10       81 ± 12             82 ± 12†            91 ± 7††
                                                  HH      91 ± 16       59 ± 23^\*\*^       50 ± 13^\*\*^       44 ± 7^\*\*^
                                                  SHAM    88 ± 12       86 ± 20             85 ± 20†            80 ± 17††
  Arterial O~2~ saturation                        IH      91.2 ± 2.9    90.7 ± 3.4          90.1 ± 3.0†         91.8 ± 2.8††
                                                  HH      96.3 ± 3.0    69.9 ± 21.9^\*^     60.0 ± 22.0^\*^     52.3 ± 15.8^\*\*^
                                                  SHAM    96.1 ± 3.6    95.7 ± 3.2          94.9 ± 4.6†         93.0 ± 7.5††
  Mixed venous pH                                 IH      7.31 ± 0.06   7.28 ± 0.08         7.19 ± 0.11^\*^     7.09 ± 0.11^\*\*^
                                                  HH      7.36 ± 0.08   7.23 ± 0.10^\*\*^   7.17 ± 0.13^\*\*^   7.10 ± 0.13^\*\*^
                                                  SHAM    7.33 ± 0.09   7.33 ± 0.10         7.33 ± 0.10         7.34 ± 0.12§
  Mixed venous P[CO]{.smallcaps}~2~ (mmHg)        IH      41 ± 3        43 ± 4              46 ± 4              49 ± 5^\*^
                                                  HH      36 ± 5        47 ± 9^\*^          52 ± 12^\*^         59 ± 15^\*^
                                                  SHAM    36 ± 5        35 ± 6              33 ± 4§§            32 ± 6§§
  Mixed venous P[O]{.smallcaps}~2~ (mmHg)         IH      34 ± 4        27 ± 6^\*\*^        20 ± 5^\*\*^        18 ± 4^\*\*^
                                                  HH      38 ± 7        30 ± 11             28 ± 10^\*\*^       24 ± 8^\*\*^
                                                  SHAM    40 ± 6        36 ± 8              42 ± 9§             43 ± 9§§
  Mixed venous O~2~ saturation                    IH      44.6 ± 11.0   28.4 ± 14.3^\*^     16.4 ± 10.1^\*\*^   11.2 ± 3.3^\*\*^
                                                  HH      52.9 ± 11.8   33.4 ± 21.5^\*^     26.6 ± 18.6^\*^     19.0 ± 12.0^\*\*^
                                                  SHAM    55.2 ± 12.1   53.3 ± 10.9‡        48.5 ± 16.5§§       48.8 ± 18.5§§
  Mesenteric venous pH                            IH      7.30 ± 0.09   7.28 ± 0.10         7.21 ± 0.12^\*^     7.15 ± 0.14^\*^
                                                  HH      7.35 ± 0.10   7.21 ± 0.13^\*\*^   7.16 ± 0.15^\*\*^   7.10 ± 0.16^\*\*^
                                                  SHAM    7.35 ± 0.09   7.35 ± 0.09         7.33 ± 0.10         7.34 ± 0.10§
  Mesenteric venous P[CO]{.smallcaps}~2~ (mmHg)   IH      42 ± 4        43 ± 4              44 ± 4              44 ± 5
                                                  HH      39 ± 9        49 ± 14             54 ± 18             60 ± 21
                                                  SHAM    36 ± 4        33 ± 4§             33 ± 4§             32 ± 6§
  Mesenteric venous P[O]{.smallcaps}~2~ (mmHg)    IH      38 ± 8        32 ± 6^\*^          25 ± 4^\*^          25 ± 4^\*^
                                                  HH      38 ± 6        33 ± 10             29 ± 10^\*^         26 ± 9^\*^
                                                  SHAM    43 ± 7        42 ± 10             42 ± 9‡             43 ± 9§
  Mesenteric venous O~2~ saturation               IH      52.3 ± 16.8   41.6 ± 13.3^\*\*^   30.2 ± 11.5^\*\*^   20.3 ± 4.9^\*\*^
                                                  HH      57.5 ± 15.0   36.2 ± 23.1^\*^     29.1 ± 23.2^\*^     23.9 ± 17.5^\*\*^
                                                  SHAM    67.5 ± 10.5   63.3 ± 14.6         63.3 ± 14.6‡‡†      65.1 ± 16.4§§

^\*^*P* \< 0.05 versus basal; ^\*\*^*P* \< 0.01 versus basal; † *P* \< 0.05 versus hypoxic hypoxia; †† *P* \< 0.01 versus hypoxic hypoxia; ‡ *P*\< 0.05 versus ischemic hypoxia; ‡‡ *P* \< 0.01 versus ischemic hypoxia; §*P* \< 0.05 versus ischemic and hypoxic hypoxia; §§ *P* \< 0.01 versus ischemic and hypoxic hypoxia (paired or unpaired *t*-tests with Bonferroni correction, after analysis of variance \< 0.05).

Systemic and intestinal supply dependence was induced in both the IH and HH groups. There were no significant changes in systemic and intestinal D[O]{.smallcaps}~2~ and V[O]{.smallcaps}~2~ in the sham group (Figure [1](#F1){ref-type="fig"}). In the IH group, supply dependence appeared with critical decreases in CO and superior mesenteric artery blood flow (0.104 ± 0.024 versus 0.048 ± 0.006 l/min per kg, and 0.664 ± 0.227 versus 0.258 ± 0.082 l/min per kg, respectively; *P* \< 0.0001). In the HH group it was due to a progressive decrease in arterial oxygenation. CO and intestinal blood flow were maintained (0.446 ± 0.085 versus 0.431 ± 0.140 ml/min per kg, respectively; not significant), owing to the administration of normal saline (median 630 ml; range 20--1310 ml). Arterial and intra-mucosal pH fell significantly in the IH and HH groups. In the HH group it was primarily related to systemic respiratory and metabolic acidosis (Tables [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}), because ΔP[CO]{.smallcaps}~2~ did not increase. In addition, systemic and intestinal venoarterial P[CO]{.smallcaps}~2~ gradients were not modified. CO~2~ content differences also did not change (Table [2](#T2){ref-type="table"} and Figure [2](#F2){ref-type="fig"}). In contrast, in the IH group, ΔP[CO]{.smallcaps}~2~, systemic and intestinal venoarterial P[CO]{.smallcaps}~2~, and CO~2~ content gradients increased significantly (Table [2](#T2){ref-type="table"} and Figure [2](#F2){ref-type="fig"}). In the sham group, CO~2~ gradients and pH~i~ remained unchanged.

![Systemic and intestinal oxygen supply dependence. **(a)** Relationship between systemic oxygen transport and consumption during ischemic and hypoxic hypoxia, and in the sham group. **(b)** Relationship between intestinal oxygen transport and consumption during ischemic and hypoxic hypoxia, and in the sham group. Data are expressed as means ± SEM. ^\*^*P* \< 0.05 versus basal oxygen consumption. §*P* \< 0.05 versus sham group.](cc1813-1){#F1}

![Relationship between intestinal oxygen transport and intramucosal--arterial P[CO]{.smallcaps}~2~ difference during ischemic and hypoxic hypoxia, and in the sham group. Data are expressed as means ± SEM. ^\*^*P* \< 0.05 versus basal intramucosal--arterial P[CO]{.smallcaps}~2~ difference. § *P* \< 0.05 versus hypoxic hypoxia and sham group.](cc1813-2){#F2}

###### 

CO~2~ gradients and intramucosal pH during ischemic hypoxia (IH) and hypoxic hypoxia (HH), and in the sham group

  Parameter                                                  Group   Basal         30 minutes          60 minutes          90 minutes
  ---------------------------------------------------------- ------- ------------- ------------------- ------------------- -------------------
  Mixed venous--arterial P[CO]{.smallcaps}~2~ (mmHg)         IH      8 ± 2         12 ± 3^\*^†         19 ± 5^\*\*^††      25 ± 4^\*\*^††
                                                             HH      7 ± 2         7 ± 3               8 ± 3               9 ± 3
                                                             SHAM    5 ± 2         7 ± 3†              6 ± 3‡‡             5 ± 3‡‡
  Mixed venous--arterial CO~2~ content (vol%)                IH      4.3 ± 1.6     7.2 ± 4.8           10.9 ± 2.5^\*^††    14.3 ± 3.6^\*^††
                                                             HH      4.6 ± 1.7     3.5 ± 1.4           3.4 ± 2.0           3.2 ± 1.0
                                                             SHAM    4.0 ± 4.8     5.7 ± 3.1           6.9 ± 2.1           2.7 ± 1.8‡‡
  Mesenteric venous--arterial P[CO]{.smallcaps}~2~ (mm Hg)   IH      9 ± 4         12 ± 3^\*^††        16 ± 4^\*\*^        19 ± 5††‡
                                                             HH      9 ± 5         5 ± 3               20 ± 10             6 ± 2
                                                             SHAM    6 ± 3         5 ± 2‡‡             6 ± 1‡‡             5 ± 2‡‡
  Mesenteric venous--arterial CO~2~ content (vol%)           IH      4.7 ± 1.2     7.2 ± 3.2           8.2 ± 2.4^\*^††     9.8 ± 2.2^\*^††
                                                             HH      6.6 ± 5.7     3.8 ± 2.6           3.4 ± 2.4           3.4 ± 2.3
                                                             SHAM    3.0 ± 1.9     3.3 ± 1.1           5.4 ± 2.4           2.6 ± 1.8‡‡
  Intramucosal--arterial P[CO]{.smallcaps}~2~ (mmHg)         IH      12 ± 10       19 ± 12^\*^†        32 ± 17^\*\*^††     40 ± 13^\*\*^††¶
                                                             HH      13 ± 6        8 ± 8               13 ± 11             10 ± 13
                                                             SHAM    8 ± 5         11 ± 3‡             10 ± 4‡‡            9 ± 6‡‡
  Intramucosal--arterial CO~2~ content (vol%)                IH      2.0 ± 0.4     2.4 ± 0.6††         2.8 ± 0.8^\*^††     3.3 ± 0.8^\*\*^††
                                                             HH      2.0 ± 0.5     0.7 ± 0.8           0.9 ± 0.9           0.3 ± 1.2
                                                             SHAM    1.7 ± 0.4     1.9 ± 0.7           2.1 ± 0.9           1.7 ± 0.5‡
  Intramucosal Ph                                            IH      7.24 ± 0.14   7.16 ± 0.16^\*\*^   7.01 ± 0.22^\*\*^   6.84 ± 0.21^\*\*^
                                                             HH      7.26 ± 0.14   7.19 ± 0.13^\*\*^   7.10 ± 0.16^\*\*^   7.07 ± 0.18^\*\*^
                                                             SHAM    7.28 ± 0.06   7.26 ± 0.09         7.17 ± 0.08         7.25 ± 0.10§§

^\*^*P* \< 0.05 versus basal; ^\*\*^*P* \< 0.01 versus basal; † *P* \< 0.05 versus hypoxic hypoxia; †† *P* \< 0.01 versus hypoxic hypoxia; ‡ *P* \< 0.05 versus ischemic hypoxia; ‡‡ *P* \< 0.01 versus ischemic hypoxia; §*P* \< 0.05 versus ischemic and hypoxic hypoxia; §§ *P* \< 0.01 versus ischemic and hypoxic hypoxia (paired or unpaired *t*-tests with Bonferroni correction, after analysis of variance \< 0.05).

Discussion
==========

Increased mucosal intestinal P[CO]{.smallcaps}~2~ is used as a tool to detect delivery can no tissue dysoxia, the condition in which O~2~ longer sustain O~2~ uptake \[[@B11]\]. A great body of literature supports the role of intestinal P[CO]{.smallcaps}~2~ as an early marker of dysoxia and regional hypoperfusion. Early studies considered pH~i~ as the reference parameter. Recently, some investigators have claimed that intramucosal P[CO]{.smallcaps}~2~, the variable actually measured by the tonometer, and ΔP[CO]{.smallcaps}~2~ could more adequately reflect mucosal oxygenation \[[@B6],[@B12]\]. pH~i~ is a calculated variable, from the Henderson--Hasselbach equation, with the assumption that arterial bicarbonate is representative of intra-mucosal bicarbonate. In a steady state, both values might be similar. However, in rapidly changing physiological situations, differences between arterial and mucosal CO~2~ might arise owing to slow CO~2~ equilibrium kinetics \[[@B13]\]. Therefore, pH~i~ values calculated from tonometry might differ from those directly measured with tissue electrodes \[[@B14]\]. Moreover, acid--base states could influence in the absence of pH~i~ altered mucosal oxygenation. As a result, the acid--base status of arterial blood will be reflected in both mucosal pH~i~ and P[CO]{.smallcaps}~2~ \[[@B6],[@B14]\]. In our experiments, pH~i~ fell progressively during hydrochloric acid-induced lung injury and decreased D[O]{.smallcaps}~2~, reflecting ongoing systemic respiratory and metabolic acidosis. However, ΔP[CO]{.smallcaps}~2~ remained unchanged.

Another issue that has been discussed extensively is the relative impact on mucosal P[CO]{.smallcaps}~2~ of anaerobic production of CO~2~ in comparison with decreased washout of aerobically generated CO~2~ during low flow states. Many investigators \[[@B15],[@B16],[@B17]\] have ascribed increased P[CO]{.smallcaps}~2~ found in shock states to continuing aerobic CO~2~ production with decreased elimination; that is, to \'respiratory acidosis\'. However, Schlichtig and Bowles \[[@B7]\] showed evidence supporting the role of intramu-cosal P[CO]{.smallcaps}~2~ as a marker of dysoxia in extreme hypoperfusion, when V[O]{.smallcaps}~2~ falls. In a dog model of cardiac tamponade, they demonstrated that mucosal P[CO]{.smallcaps}~2~ could rise because of anaerobic CO~2~ production below the critical D[O]{.smallcaps}~2~. These conclusions were drawn by using the Dill nomogram, which can theoretically detect anaerobic CO~2~ production from a comparison of the measured (%HbO~2,v~) and calculated (%HbO~2,v~^Dill^) venous oxyhemoglobin, within a given venous P[CO]{.smallcaps}~2~ value. Because venous P[CO]{.smallcaps}~2~ is considered to be representative of tissue P[CO]{.smallcaps}~2~, Schlichtig and Bowles made the calculation with its intestinal equivalent, intramucosal P[CO]{.smallcaps}~2~. If %HbO~2,v~^Dill^ is lower than the measured %HbO~2,v~, anaerobic production of CO~2~ might be assumed. Similar values would represent aerobic CO~2~ generation. Notwithstanding the original contribution of Schlichtig and Bowles \[[@B7]\] to the analysis of these topics, the use of low flow to produce critical oxygen delivery and falling V[O]{.smallcaps}~2~ has been signaled as a potential confounding factor \[[@B18]\].

We studied these issues in a model of HH with preserved flow, because it allows a clear discrimination between hypoxia and hypoperfusion. There have been attempts to analyze pH~i~ behavior in HH, but critical intestinal D[O]{.smallcaps}~2~ was not attained, and intestinal V[O]{.smallcaps}~2~ and pH~i~ remained unchanged \[[@B2]\]. Our model consisted of an acute lung injury produced by endotracheal instillation of hydrochloric acid that rapidly generated severe hypoxemia, shown by the decrease in arterial P[O]{.smallcaps}~2~ and pH. The acid also enhanced microvascular permeability \[[@B19],[@B20],[@B21]\], demonstrated by increased requirements of saline solution to maintain intestinal blood flow and by the increase in hemoglobin levels. However, other mechanisms could be acting to preserve blood flow, such as tachycardia and enhanced left ventricular contractility \[[@B22]\]. Deep arterial hypoxemia caused significant reductions in systemic and intestinal D[O]{.smallcaps}~2~, but systemic and intestinal blood flow were preserved and hemoglobin concentration increased. Despite the increase in systemic and intestinal oxygen extraction, systemic and intestinal V[O]{.smallcaps}~2~ values decreased, and dependence of O~2~ uptake on transport ensued. Dependence of oxygen consumption on transport during HH has been described by Cain *et al.* in a classical study \[[@B23]\], and it has been considered an indicator of anaerobic metabolism. Additional evidence of tissue dysoxia was the appearance of metabolic acidosis. Cain \[[@B24]\] also showed that there is a correlation between pH and lactate/pyruvate relationship in HH.

Another potential confounding factor that could affect arterial and intestinal P[CO]{.smallcaps}~2~ and their differences is the shift of the CO~2~ dissociation curve. As Jakob *et al.* \[[@B25]\] have shown, there can be a lack of correlation of CO~2~ contents and P[CO]{.smallcaps}~2~, and, consequently, of their differences. Many determinants of the shifts of the CO~2~ dissociation curve, such as changes in pH, in hemoglobin concentrations, and especially in oxygen saturations (the Haldane effect), were present. To discard a possible increase in venoarterial and intramucosal--arterial CO~2~ contents without changes in P[CO]{.smallcaps}~2~ differences in the HH group, we calculated CO~2~ content differences. There were no increases in venoarterial and intramucosal--arterial CO~2~ content differences during the period of supply dependence, as there were no changes in both P[CO]{.smallcaps}~2~ differences. Shifts of the CO~2~ dissociation curve therefore do not seem to influence our results.

Our model of HH is useful for discriminating the effects of hypoxia and low blood flow, because this last factor was kept constant throughout the experiment. ΔP[CO]{.smallcaps}~2~ remained stable, although there were signs of anaerobic metabolism. Systemic and venoarterial P[CO]{.smallcaps}~2~ differences also remained unchanged. Conversely, during supply dependence of V[O]{.smallcaps}~2~ induced by hemorrhage, ΔP[CO]{.smallcaps}~2~ and systemic and intestinal venoarterial P[CO]{.smallcaps}~2~ differences widened, as well as the respective ΔP[CO]{.smallcaps}~2~ content differences. Moreover, these parameters increased before any change in V[O]{.smallcaps}~2~, as we have described previously \[[@B26]\]. These results suggest that, at least in our experiments, tissue perfusion is a key determinant of increased ΔP[CO]{.smallcaps}~2~.

Nevière *et al.* \[[@B27]\] tested a similar hypothesis in pigs. They compared the effects of diminished blood flow with diminished inspired fraction of oxygen. In IH, ΔP[CO]{.smallcaps}~2~ increased to 60 mmHg. In HH, ΔP[CO]{.smallcaps}~2~ increased to 30 mmHg only in the last step of hypoxemia, although mucosal blood flow measured by laser Doppler flowmetry was preserved. The authors concluded that elevated intramucosal P[CO]{.smallcaps}~2~ indicated local CO~2~ generation. However, in the two previous stages of reduced F~i~[O]{.smallcaps}~2~ there was supply dependence, and ΔP[CO]{.smallcaps}~2~ remained unchanged. In our HH model, ΔP[CO]{.smallcaps}~2~ was also stable. The differences between our data and those of Nevière *et al.* \[[@B27]\] could be ascribed to distinct microvascular features of the experimental subjects (pigs and sheep) or to different degrees of hypoxemia. In addition, as Nevière *et al.* pointed out, some degree of decrease in gut mucosal blood flow and heterogeneity might have been present, because only global microvascular blood flow changes can be assessed by laser Doppler flowmetry. Nevertheless, both studies show that ΔP[CO]{.smallcaps}~2~ could fail to reflect tissue dysoxia at some time during HH. In results similar to ours, Vallet *et al.* \[[@B28]\] showed that perfusion is a major determinant of venoarterial P[CO]{.smallcaps}~2~ difference during critical IH or HH in isolated hindlimb. This gradient increases in ischemia and is preserved in hypoxia.

Venoarterial and intramucosal--arterial P[CO]{.smallcaps}~2~ gradients are the result of interactions of changes in aerobic and anaerobic CO~2~ production, the CO~2~ dissociation curve, and blood flow to tissues. During oxygen supply dependence induced by hemorrhage, opposite changes in aerobic and anaerobic CO~2~ production are present: aerobic CO~2~ production decreases as a consequence of depressed aerobic metabolism, but anaerobic CO~2~ production starts because of bicarbonate buffering of protons from fixed acids. Total CO~2~ production might not increase, but O~2~ consumption falls, so there is an increase in respiratory quotient \[[@B29],[@B30]\]. This increase in V[CO]{.smallcaps}~2~ relative to V[O]{.smallcaps}~2~ might generate tissue and venous hypercarbia only in low flow states, in which there is diminished CO~2~ removal. Other situations in which intramucosal acidosis could arise with preserved tissue perfusion are reperfusion injury \[[@B31]\] and cytopathic hypoxia generated by endotoxemia \[[@B32]\], with cellular damage and metabolic abnormalities as underlying mechanisms. However, impaired villous microcirculation has been advocated as the causal phenomenon in the latter \[[@B33]\].

Conclusions
===========

To our knowledge, this is the first study showing that ΔP[CO]{.smallcaps}~2~ fails to mirror intestinal tissue dysoxia. Our findings also suggest that blood flow might be the main determinant of ΔP[CO]{.smallcaps}~2~. Tonometry seems to be a useful method for monitoring perfusion, with rather limited value in detecting anaerobic metabolism when blood flow is preserved. Additional studies in other models of hypoxic and anemic hypoxia are needed to confirm our findings and to resolve discrepancies between studies.
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Key messages
============

• The intramucosal--arterial P[CO]{.smallcaps}~2~ gradient fails to reflect intestinal oxygen supply dependence during hypoxic hypoxia

• Blood flow seems to be the main determinant of venoarterial and intramucosal--arterial P[CO]{.smallcaps}~2~ gradients

• Tonometry seems to be a useful method for monitoring perfusion, with limited value in detecting anaerobic metabolism when flow is preserved
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